Copyright
©The Author(s) 2024.
World J Diabetes. Mar 15, 2024; 15(3): 361-377
Published online Mar 15, 2024. doi: 10.4239/wjd.v15.i3.361
Published online Mar 15, 2024. doi: 10.4239/wjd.v15.i3.361
Intervention method | Cycle time, follow-up time | Effect | Ref. |
Lifestyle intervention | 4 months, 1 yr follow up | Blood glucose and lipids can be effectively controlled | Gokulakrishnan et al[28] |
Lifestyle intervention | 1 yr | Effective reduction of disease risk in patients with prediabetes | Hu et al[29] |
Lifestyle intervention | 1 yr | Weight loss 34.1% higher than in the diatomic group | Apolzan et al[30] |
Metformin | 10 yr | Enhanced glycemic control to improve health outcomes | Jonas et al[31] |
Metformin | 1 yr | More effective in body weight reduction. Better results than life interventions | O’Brien et al[32] |
Metformin | 5 yr | Weight loss 2.5% higher than life intervention group | Apolzan et al[30] |
Metformin | 15 yr | Compared with the placebo group, 17% lower incidence of diabetes | Diabetes Prevention Program Research Group[33] |
GLP-1 receptor agonist | 3 yr | Significant weight loss and improved blood sugar | le Roux et al[34] |
GLP-1 receptor agonist | 17 months | Significant weight loss | Wilding et al[35] |
GLP-1 receptor agonist | 14 wk | Significant reduction of body weight and improved relevant glucose tolerance indicators | Kim et al[36] |
- Citation: Ping WX, Hu S, Su JQ, Ouyang SY. Metabolic disorders in prediabetes: From mechanisms to therapeutic management. World J Diabetes 2024; 15(3): 361-377
- URL: https://www.wjgnet.com/1948-9358/full/v15/i3/361.htm
- DOI: https://dx.doi.org/10.4239/wjd.v15.i3.361